Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: Alternative PCR targets for detection of minimal residual disease

Leukemia

Volumn 13, Issue 2, 1999, Pages 196-205

  Szczepanski T ^a,d   Beishuizen, A ^a   Pongers Willemse, M J ^a   Hahlen K ^b,c   Van Wering, E R ^c   Wijkhuijs, A J M ^a   Tibbe, G J M ^a   De Bruijn, M A C ^a   Van Dongen, J J M ^a,e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c Dutch Childhood Leukemia Study Group   (Netherlands)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Cross lineage rearrangements; Heteroduplex PCR analysis; Minimal residual disease (MRD); Precursor B ALL; Southern blot analysis; TCR gene rearrangements

Indexed keywords

RESTRICTION ENDONUCLEASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; ARTIFICIAL MEMBRANE; CHILDHOOD LEUKEMIA; DEVICE; GENE DELETION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SOUTHERN BLOTTING; T LYMPHOCYTE RECEPTOR GENE;

EID: 0032996684     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401277     Document Type: Article

References (47)

1. Tonegawa S. Somatic generation of antibody diversity. Nature 1983; 302: 575-581.
2. Van Dongen JJM, Wolvers-Tettero ILM. Analysis of immunoglobulin and T cell receptor genes. Part I: basic and technical aspects. Clin Chim Acta 1991; 198: 1-91.
3. Greaves MF, Chan LC, Furley AJ, Watt SM, Molgaard HV. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 1986; 67: 1-11.
4. Kitchingman GR, Rovigatti U, Mauer AM, Melvin S, Murphy SB, Stass S. Rearrangement of immunoglobulin heavy chain genes in T cell acute lymphoblastic leukemia. Blood 1985; 65: 725-729.
5. Dyer MJ. T-cell receptor delta/alpha rearrangements in lymphoid neoplasms. Blood 1989; 74: 1073-1083.
6. Van Dongen JJM, Wolvers-Tettero ILM. Analysis of immunoglobulin and T cell receptor genes. Part II: possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin Chim Acta 1991; 198: 93-174.
7. Hara J, Benedict SH, Champagne E, Takihara Y, Mak TW, Minden M, Gelfand EW. T cell receptor delta gene rearrangements in acute lymphoblastic leukemia. J Clin Invest 1988; 82: 1974-1982.
8. Nuss R, Kitchingman G, Cross A, Zipf TF, Antoun GR, Bernstein I, Behm F, Pullen DJ, Crist W, Mirro J Jr, Goorha R. T cell receptor gene rearrangements in B-precursor acute lymphoblastic leukemia correlate with age and the stage of B cell differentiation. Leukemia 1988; 2: 722-727.
9. Hara J, Benedict SH, Champagne E, Mak TW, Minden M, Gelfand EW. Relationship between rearrangement and transcription of the T-cell receptor alpha, beta, and gamma genes in B-precursor acute lymphoblastic leukemia. Blood 1989; 73: 500-508.
10. Felix CA, Poplack DG, Reaman GH, Steinberg SM, Cole DE, Taylor BJ, Begley CG, Kirsch IR. Characterization of immunoglobulin and T-cell receptor gene patterns in B-cell precursor acute lymphoblastic leukemia of childhood. J Clin Oncol 1990; 8: 431-442.
11. Fey MF, Tobler A, Stadelmann B, Hirt A, Theilkas L, Khandjian EW, Ridolfi-Luthy A, Delaleu B, Weil R, Wagner HP. Immunogenotyping with antigen receptor gene probes as a diagnostic tool in childhood acute lymphoblastic leukaemia. Eur J Haematol 1990; 45: 215-222.
12. Biondi A, Francia di Celle P, Rossi V, Casorati G, Matullo G. Giudici G, Foa R, Migone N. High prevalence of T-cell receptor V delta 2-(D)-D delta 3 or D delta 1/2-D delta 3 rearrangements in B-precursor acute lymphoblastic leukemias. Blood 1990; 75: 1834-1840.
13. Breit TM, Wolvers-Tettero ILM, Beishuizen A, Verhoeven M-AJ, Van Wering ER, Van Dongen JJM. Southern blot patterns, frequencies and junctional diversity of T-cell receptor δ gene rearrangements in acute lymphoblastic leukemia. Blood 1993; 82: 3063-3074.
14. Campana D, Pui CH. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 1995; 85: 1416-1434.
15. Van Dongen JJM, Szczepañski T, De Bruijn MAC, Van den Beemd MWM, De Bruin-Versteeg S, Wijkhuijs JM, Tibbe GJM, Van Gastel-Mol EJ, Groeneveld K, Hooijkaas H. Detection of minimal residual disease in acute leukemia patients. Cytokines Mol Ther 1996; 2: 121-133.
16. Seriu T, Erz D, Stark Y, Bartram CR. T cell receptor Ddelta2D-delta3 rearrangement: a suitable allele-specific marker for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia 1997; 11: 759-761.
17. Van Dongen JJM, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, Van Wering ER, Ludwig W-D, Basso G, De Bruijn MAC, Cazzaniga G, Hettinger K, Van der Does-Van den Berg A, Hop WCJ, Riehm H, Bartram CR. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998; 352: 1731-1738.
18. Bottaro M, Berti E, Biondi A, Migone N, Crosti L. Heteroduplex analysis of T-cell receptor gamma gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas. Blood 1994; 83: 3271-3278.
19. Langerak AW, Szczepański T, Van der Burg M, Wolvers-Tettero ILM, Van Dongen JJM. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 1997; 11: 2192-2199.
20. Beishuizen A, De Bruijn MAC, Pongers-Willemse MJ, Verhoeven M-AJ, Van Wering ER, Hählen K, Breit TM, De Bruin-Versteeg S, Hooijkaas H, Van Dongen JJM. Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease. Leukemia 1997; 11: 2200-2207.
21. Szczepański T, Langerak AW, Wolvers-Tettero ILM, Ossenkoppele GJ, Verhoef G, Stul M, Petersen EJ, De Bruijn MAC, Van't Veer MB, Van Dongen JJM. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease. Leukemia 1998; 12: 1081-1088.
22. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451-458.
23. Van Dongen JJ, Adriaansen HJ, Hooijkaas H. Immunophenotyping of leukaemias and non-Hodgkin's lymphomas. Immunological markers and their CD codes. Neth J Med 1988; 33: 298-314.
24. Van der Does-Van den Berg A, Bartram CR, Basso G, Benoit YC, Biondi A, Debatin KM, Haas OA, Harbott J, Kamps WA, Koller U, Lampert F, Ludwig W-D, Niemeyer CM, Van Wering ER. Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the 'BFM Family' Cooperative Group. Med Pediatr Oncol 1992; 20: 497-505.
25. Groeneveld K, Te Marvelde JG, Van den Beemd MW, Hooijkaas H, Van Dongen JJM. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes. Leukemia 1996; 10: 1383-1389.
26. LeFranc MP, Forster A, Baer R, Stinson MA, Rabbitts TH. Diversity and rearrangement of the human T cell rearranging gamma genes: nine germ-line variable genes belonging to two subgroups. Cell 1986; 45: 237-246.
27. Quertermous T, Strauss WM, Van Dongen JJM, Seidman JG. Human T cell gamma chain joining regions and T cell development. J Immunol 1987; 138: 2687-2690.
28. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, a Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989.
29. Breit TM, Wolvers-Tettero ILM, Hählen K, Van Wering ER, Van Dongen JJM. Extensive junctional diversity of γδ T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease. Leukemia 1991; 5: 1076-1086.
30. Pongers-Willemse MJ, Seriu T, Stolz F, d'Aniello E, Gameiro P, Pisa P, Gonzalez M, Bartram CR, Panzer-Grumayer ER, Biondi A, San Miguel JF, Van Dongen JJM. Primers and protocols for standardized MRD detection in ALL using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Report of the BIOMED-1 Concerted Action investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 110-118.
31. Foroni L, Foldi J, Matutes E, Catovsky D, O'Connor NJ, Baer R, Forster A, Rabbitts TH, Luzzatto L. Alpha, beta and gamma T-cell receptor genes: rearrangements correlate with haematological phenotype in T cell leukaemias. Br J Haematol 1987; 67: 307-318.
32. Kneba M, Bergholz M, Bolz I, Hulpke M, Batge R, Schauer A, Krieger G. Heterogeneity of immunoglobulin gene rearrangements in B-cell lymphomas. Int J Cancer 1990; 45: 609-613.
33. Height SE, Swansbury GJ, Matutes E, Treleaven JG, Catovsky D, Dyer MJ. Analysis of clonal rearrangements of the Ig heavy chain locus in acute leukemia. Blood 1996; 87: 5242-5250.
34. Yancopoulos GD, Blackwell TK, Suh H, Hood L, Alt FW. Introduced T cell receptor variable region gene segments recombine in pre-B cells: evidence that B and T cells use a common recombinase. Cell 1986; 44: 251-259.
35. Foroni L, Coyle LA, Papaioannou M, Yaxley JC, Sinclair MF, Chim JS, Cannell P, Secker-Walker LM, Mehta AB, Prentice HG, Hoffbrand AV. Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response. Leukemia 1997; 11: 1732-1741.
36. Beishuizen A, Hählen K, Hagemeijer A, Verhoeven MA, Hooijkaas H, Adriaansen HJ, Wolvers-Tettero ILM, Van Wering ER, Van Dongen JJM. Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin. Leukemia 1991; 5: 657-667.
37. Steward CG, Goulden NJ, Katz F, Baines D, Martin PG, Langlands K, Potter MN, Chessells JM, Oakhill A. A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia. Blood 1994; 83: 1355-1362.
38. Baruchel A, Cayuela JM, MacIntyre E, Berger R, Sigaux F. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection. Br J Haematol 1995; 90: 85-93.
39. Ghali DW, Panzer S, Fischer S, Argyriou-Tirita A, Haas OA, Kovar H, Gadner H, Panzer-Grumayer ER. Heterogeneity of the T-cell receptor delta gene indicating subclone formation in acute precursor B-cell leukemias. Blood 1995; 85: 2795-2801.
40. Steenhergen EJ, Verhagen OJ, Van Leeuwen EF, Van den Berg H, Von dem Borne AE, Van der Schoot CE. Frequent ongoing T-cell receptor rearrangements in childhood B-precursor acute lymphoblastic leukemia: implications for monitoring minimal residual disease. Blood 1995; 86: 692-702.
41. Taylor JJ, Rowe D, Kylefjord H, Chessells J, Katz F, Proctor SJ, Middleton PG. Characterisation of non-concordance in the T-cell receptor gamma chain genes at presentation and clinical relapse in acute lymphoblastic leukemia. Leukemia 1994; 8: 60-66.
42. Wasserman R, Yamada M, Ito Y, Finger LR, Reichard BA, Shane S, Lange B, Rovera G. VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 223-228.
43. Steenbergen EJ, Verhagen OJ, Van den Berg H, Van Leeuwen EF, Behrendt H, Slater RR, Von dem Borne AE, Van der Schoot CE. Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia. Leukemia 1997; 11: 1258-1265.
44. Beishuizen A, Verhoeven MA, Van Wering ER, Hählen K, Hooijkaas H, Van Dongen JJM. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis. Blood 1994; 83: 2238-2247.
45. Marshall GM, Kwan E, Haber M, Brisco MJ, Sykes PJ, Morley AA, Toogood I, Waters K, Tauro G, Ekert H, Norris MD. Characterization of clonal immunoglobulin heavy chain and T cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia. Leukemia 1995; 9: 1847-1850.
46. Pongers-Willemse MJ, Verhagen OJHM, Tibbe GJM, Wijkhuijs JM, De Haas V, Roovers E, Van der Schoot CE, Van Dongen JJM. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional regions specific TaqMan probes. Leukemia 1998; 12: 2006-2014.
47. + T cell acute lymphoblastic leukemia. Leukemia 1999; 13: 206-214.